Quick Takeaways
- Sumitomo Mitsui Trust Group, Inc. filed SCHEDULE 13G/A for Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share (ARCT).
- Disclosed ownership: 7.2%.
- Date of event: 30 Sep 2025.
Sumitomo Mitsui Trust Group, Inc. - 30 Sep 2025 SCHEDULE 13G/A Report for Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share (ARCT)
- Filing Manager
- Sumitomo Mitsui Trust Group, Inc.
- Reporting Manager
- Sumitomo Mitsui Trust Group, Inc.
- Symbol
- ARCT
- Shares outstanding
- 27,053,264 shares
- Disclosed Ownership
- 1,947,835 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 27 Oct 2025, 06:57:10 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 25 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sumitomo Mitsui Trust Group, Inc. disclosed 7.2% ownership in Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share (ARCT) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 25 Apr 2025.
- Current filing was accepted on 27 Oct 2025, 06:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sumitomo Mitsui Trust Group, Inc. | 7.2% | 1,947,835 | 0 | 1,947,835 | /s/ Hideaki Takamiya | Senior Manager of Risk Management Dept | |
| Amova Asset Management Co., Ltd. | 7.2% | 1,947,835 | 0 | 1,947,835 | /s/ Atsushi Ohya | Head of Business Regulatory Compliance |